Toxoplasmosis in Cats: Zoonotic Risk and Pregnancy

1. Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [1, 2]. The parasite infects virtually all warm-blooded vertebrates, with felids serving as the definitive hosts [2, 3]. Cats are uniquely responsible for the environmental dissemination of the infectious oocyst stage, making them central to the epidemiology of toxoplasmosis [2, 4]. In humans, primary infection during pregnancy carries a risk of congenital transmission, resulting in severe fetal and neonatal disease, including chorioretinitis, hydrocephalus, and intracranial calcifications [5, 6]. This article provides an exhaustive review of feline toxoplasmosis with a specific focus on zoonotic risk during pregnancy, emphasizing the clinical, diagnostic, and preventive considerations for veterinary practitioners. The term “cat toxoplasmosis baby” encapsulates the core public health concern linking feline shedding to human congenital infection.

2. Etiology and Life Cycle

Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (within tissue cysts), and sporozoites (within oocysts) [2]. The sexual cycle occurs exclusively in the intestinal epithelium of felids, where macrogametes and microgametes fuse to form oocysts that are shed in feces [2, 7]. After a prepatent period of 3–10 days post-ingestion of tissue cysts, cats can excrete millions of unsporulated oocysts per day for 1–3 weeks [2, 8]. Sporulation occurs in the environment within 1–5 days, rendering oocysts highly resistant to desiccation, freezing, and standard disinfectants [2, 9].

The asexual cycle takes place in intermediate hosts (including humans) and in cats themselves. Following ingestion of oocysts or tissue cysts, tachyzoites disseminate via the bloodstream, eventually converting to bradyzoites that form tissue cysts predominantly in neural and muscular tissues [7, 10]. Tissue cysts remain viable for the lifetime of the host, serving as a source of recrudescent infection during immunosuppression [10, 11].

Cats can acquire infection through three main routes: ingestion of tissue cysts from infected prey or raw meat, ingestion of sporulated oocysts from the environment, and vertical transmission (transplacental or transmammary) [7, 12, 31]. The prepatent period varies by route: 3–10 days for tissue cyst ingestion, 19–48 days for oocyst ingestion, and typically longer for congenital infection [2, 7].

3. Epidemiology

Seroprevalence of T. gondii in domestic cats varies widely by geographic region, cat population (pet versus stray), age, and diagnostic method [3, 13, 32]. Table 1 summarizes representative seroprevalence studies from the published literature.

Table 1. Global seroprevalence of Toxoplasma gondii in cats

Risk factors consistently associated with seropositivity include older age [17, 32], outdoor access [15, 14], hunting behavior [2, 18], and lack of regular veterinary care [32]. Stray and semi-domesticated cats consistently demonstrate higher seroprevalence than owned indoor-only cats, reflecting greater exposure to infected prey and environmental oocysts [15, 14, 16].

4. Clinical Signs and Pathology

Clinical toxoplasmosis in cats is relatively uncommon despite high seroprevalence; most infections remain subclinical [10, 5]. Disease occurs most frequently in kittens, immunocompromised adults, or cats with concurrent viral infections such as feline immunodeficiency virus (FIV) or feline leukemia virus (FeLV) [4, 10]. A retrospective analysis of 100 histologically confirmed cases identified the following lesion distributions: generalized (36%), predominantly pulmonary (26%), abdominal (16%), neurologic (7%), and neonatal (9%) [10].

Common clinical signs include fever, anorexia, dyspnea, tachypnea, icterus, abdominal discomfort, and neurological deficits such as ataxia, seizures, and cranial nerve abnormalities [19, 10, 20]. Ocular involvement is frequent; in one study, 22 of 27 (81.5%) cats with systemic toxoplasmosis had intraocular inflammation, most commonly iridocyclochoroiditis [10, 21]. The ciliary body is the most severely affected uveal structure [10].

Neonatal toxoplasmosis presents with fulminant multisystemic disease, often resulting in death within the first weeks of life [12, 31]. Lesions include hepatitis, pneumonitis, myocarditis, and encephalitis, with widespread tachyzoites and tissue cysts [12]. Kittens born to queens infected during gestation may exhibit failure to thrive, neurological deficits, or ocular lesions [12, 31].

5. Zoonotic Risk and Pregnancy

5.1. Transmission Pathways to Humans

Humans acquire T. gondii through three principal routes: ingestion of undercooked meat containing tissue cysts, ingestion of food or water contaminated with sporulated oocysts from cat feces, and vertical transmission from mother to fetus [2, 6]. Oocyst-mediated transmission is particularly relevant to cat ownership and environmental exposure [3, 16]. A single cat can excrete millions of oocysts during acute infection, contaminating soil, gardens, and indoor surfaces [2, 8].

5.2. Cat Toxoplasmosis Baby: Congenital Transmission

Congenital toxoplasmosis occurs when a pregnant woman acquires a primary T. gondii infection and tachyzoites cross the placenta [5, 6]. The risk and severity of fetal infection depend on the gestational stage at which maternal infection occurs; risk is lowest in the first trimester (approximately 15%) but highest in the third trimester (approximately 65%) [5, 6]. However, fetal disease is most severe when infection occurs early in pregnancy, potentially leading to miscarriage, hydrocephalus, microcephaly, chorioretinitis, and cerebral calcifications [5, 6].

The phrase “cat toxoplasmosis baby” highlights the perceived link between feline contact and human congenital infection. While direct contact with a cat is not the primary risk factor (since freshly shed oocysts require 1–5 days to sporulate and become infectious), pregnant women who clean litter boxes or engage in gardening where cats defecate are at elevated risk [9, 6]. Stray cats and cats with outdoor access are more likely to be shedding oocysts, and the presence of feral cat colonies near homes increases environmental contamination [15, 16].

5.3. Role of Cat Genotype in Zoonotic Potential

The genotype of T. gondii influences virulence in both cats and humans. In China, genotype ToxoDB #9 (Chinese 1) is highly prevalent in cats and has been linked to human outbreaks and severe clinical disease [2]. Conversely, genotype #4, common in North American wildlife, was identified in an overwhelming disseminated toxoplasmosis outbreak in shelter kittens [31]. Genetic typing of feline isolates is essential for understanding regional zoonotic risk [33, 35].

6. Diagnostic Approaches

Diagnosis of toxoplasmosis in cats relies on a combination of serology, molecular detection, cytology, and histopathology [22, 5, 23]. Figure 1 presents a diagnostic decision tree.

graph TD
    A[Clinical suspicion of toxoplasmosis], > B{Serology (IgG/IgM)}
    B, >|IgG positive, IgM negative| C[Latent infection, low activity]
    B, >|IgM positive or rising IgG| D[Active or recent infection]
    D, > E{Further testing based on signs}
    E, >|Respiratory signs| F[Tracheal wash cytology or BAL fluid PCR]
    E, >|Neurological signs| G[CSF serology or PCR]
    E, >|Ocular signs| H[Serum toxoplasma antibody, aqueous humor PCR or antibody coefficient]
    E, >|Systemic illness| I[Blood or tissue PCR; consider FeLV/FIV testing]
    C, > J[Minimal intervention; monitor if immunosuppressed]
    F, >|Tachyzoites or T. gondii DNA| K[Confirm active toxoplasmosis]
    G, >|T. gondii DNA in CSF| K
    H, >|Positive aqueous PCR or local antibody production| K
    I, >|Positive PCR or cytology| K
    K, > L[Initiate treatment with clindamycin or trimethoprim-sulfonamide]
    J, > M[Recheck if clinical change]

Figure 1. Diagnostic workflow for feline toxoplasmosis. (BAL = bronchoalveolar lavage; CSF = cerebrospinal fluid; FeLV = feline leukemia virus; FIV = feline immunodeficiency virus.)

6.1. Serological Tests

The modified agglutination test (MAT) using formalin-preserved tachyzoites is highly sensitive for detecting anti-T. gondii antibodies in cats [22]. Enzyme-linked immunosorbent assays (ELISA) for IgG and IgM are widely used, with IgG indicating prior exposure and IgM suggesting recent or active infection [22, 9]. However, IgM can persist for months, and its absence does not rule out active disease [9].

Recent work has compared recombinant antigens for serodiagnosis. Sabukunze et al. (2024) found that GRA7 (dense granule protein 7) exhibited superior sensitivity compared to SAG2 and GRA6 in feline ELISA [23]. GRA3 expressed in a cell-free system also showed promise as a diagnostic antigen [23].

6.2. Molecular Detection

Polymerase chain reaction (PCR) targeting the B1 gene or 529 bp repetitive element is routinely used to detect T. gondii DNA in blood, aqueous humor, CSF, bronchoalveolar lavage fluid, or tissue biopsies [14, 5, 16]. PCR is particularly useful for confirming active infection in immunocompromised cats or when serology is equivocal [4, 14]. Real-time PCR (qPCR) also allows quantification of parasite burden.

6.3. Cytology and Histopathology

Cytological examination of tracheal wash fluid, pleural effusion, or cerebrospinal fluid may reveal tachyzoites, but sensitivity is low [10, 5]. Immunohistochemical staining of biopsy or necropsy tissues using anti-T. gondii antibodies provides definitive diagnosis of tissue infection [10]. In the 100-case histopathological study, T. gondii was identified in 80% of brains, 70% of livers, and 76.7% of lungs [10].

6.4. Fecal Oocyst Detection

Microscopic examination of feces after concentration (e.g., fecal flotation) can detect oocysts, but oocyst shedding is intermittent and of short duration (1–3 weeks) [2, 8, 9]. Immunochromatographic rapid test kits provide a practical and cost-effective screening tool for cats in clinical settings, with a reported prevalence of 6% in one hospital population [1]. However, negative fecal testing does not exclude infection because most cats will have ceased shedding by the time antibodies appear [2, 11].

7. Treatment

The primary drug for feline toxoplasmosis is clindamycin hydrochloride at a dosage of 10–12 mg/kg orally every 12 hours for 4 weeks [24, 5, 30]. Clindamycin inhibits apicoplast ribosomal function and effectively reduces tachyzoite replication. Paradoxically, clindamycin has been shown to suppress but not eliminate T. gondii infection in experimentally infected cats; treated animals may remain seropositive and can recrudesce if immunosuppressed [24].

In Pallas' cats (Otocolobus manul), prophylactic clindamycin treatment reduced first-year mortality from toxoplasmosis from 100% to 5.9% in captive collections [30]. Alternative regimens include trimethoprim-sulfonamide combinations (15 mg/kg every 12 hours) or azithromycin [5]. Adjunctive therapy with corticosteroids may be necessary for ocular inflammation (anterior uveitis) to prevent secondary glaucoma [5]. Supportive care, including fluid therapy and nutritional support, is essential for severely affected cats [20].

A novel live attenuated vaccine (RHΔompdcΔuprt) developed using CRISPR-Cas9 gene editing has shown promising results in cats, reducing oocyst shedding by 95.3% and inducing strong humoral and cell-mediated immunity [25]. This vaccine is not yet commercially available but represents a future tool for controlling environmental contamination.

8. Control and Prevention

8.1. General Measures for Cat Owners

Prevention of toxoplasmosis in cats primarily involves reducing exposure to the parasite. Feeding only commercial cooked or processed cat food, preventing hunting and scavenging, and restricting outdoor access minimize acquisition of tissue cysts [2, 9]. Litter boxes should be cleaned daily (before oocysts sporulate) and disinfected with boiling water or steam [9]. Pregnant women and immunocompromised individuals should avoid changing cat litter whenever possible; if unavoidable, wearing disposable gloves and washing hands thoroughly is recommended [9, 6].

8.2. Reducing Environmental Contamination

Stray cat populations contribute heavily to soil and water contamination with oocysts [15, 16, 29]. Trap-neuter-return (TNR) programs combined with deworming and serosurveillance can reduce the burden of toxoplasmosis in free-roaming cat colonies [15, 16]. Public education about the risks of feeding stray cats and the importance of covering children’s sandboxes is crucial [16, 6].

8.3. Veterinary Clinical Management

Routine serological screening of asymptomatic pet cats for toxoplasmosis is not recommended, because positive serology merely indicates prior exposure [11, 9]. Serology is useful for diagnosing clinical disease when paired with IgM detection and PCR [22, 5]. Veterinary clinics should adopt proper handling protocols for potentially contaminated feces, including use of gloves and surface disinfection with 1% sodium hypochlorite [31].

8.4. Cat Toxoplasmosis Baby: Preventive Counseling

Pregnant women should receive specific guidance from their obstetric provider and veterinarian. The risk of T. gondii transmission from a pet cat is low if the cat is kept indoors, fed commercial food, and not allowed to hunt [2, 9]. Testing of cats for toxoplasmosis during human pregnancy is controversial; a cat that is seropositive has already shed oocysts almost certainly in the past and is unlikely to be currently shedding [22, 9]. A cat with negative IgM and IgG antibodies is not a risk for shedding unless it acquires primary infection during pregnancy. However, because a cat can become infected and shed oocysts before antibodies develop, the most prudent advice is to adopt strict hygiene measures throughout pregnancy rather than rely on serologic testing of the cat [9, 6].

9. Conclusion

Toxoplasmosis remains a significant zoonotic concern in feline veterinary practice due to the unique role of cats in disseminating environmentally resistant oocysts. While most feline infections are subclinical, clinical disease can be severe, particularly in kittens, immunocompromised animals, and individuals with concurrent retroviral infections. Comprehensive diagnostics, including serology, PCR, and histopathology, are necessary to confirm active disease. Treatment with clindamycin is effective but may not eliminate the parasite entirely. For pregnant women, the primary preventive measures are strict hygiene, avoidance of litter box handling, and limiting cat exposure to the outdoors. Continued research into vaccine development and genotypic surveillance of T. gondii in cat populations will further inform evidence-based prevention strategies.

References

[1] Parlatır Y, Şenel Y, Kara E. Determination of the Prevalance of Toxoplasmosis in Cats with Immunochoromatographic Rapid Tests Kits in Kırıkkale University Veterinary Faculty Animal Hospital. Research and Practice in Veterinary and Animal Science. 2025. URL: https://www.semanticscholar.org/paper/247f3db5fd827af96d636da4d3164d751074874f

[2] Dubey JP, Cerqueira-Cézar CK, Murata F, et al. All about toxoplasmosis in cats: the last decade. Veterinary Parasitology. 2020. URL: https://www.semanticscholar.org/paper/f0acbbba7cd9f8c048d5d0764bbf9a13fc7c158b

[3] Fux B, Covre K, Lopes R, et al. Seroprevalence of Toxoplasmosis in Cats in Espirito Santo State, Brazil. Current Developments in Nutrition. 2020. URL: https://www.semanticscholar.org/paper/c8a06a7c2da069a70425a4ee3b10947240fb5aca

[4] Munhoz A, Hage SB, Cruz R, et al. Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports. 2017. URL: https://www.semanticscholar.org/paper/7c8a2fdd2e9561c2569bc4e98397bbe347e630a2

[5] Calero-Bernal R, Gennari S. Clinical Toxoplasmosis in Dogs and Cats: An Update. Frontiers in Veterinary Science. 2019. URL: https://www.semanticscholar.org/paper/85289202e785e3bc73f8f5115e9316d859714c0c

[6] Hasan MF, Harun A, Hossain D, et al. Toxoplasmosis in animals and humans: a neglected zoonotic disease in Bangladesh. Journal of Parasitic Diseases. 2024. URL: https://www.semanticscholar.org/paper/da821e8fdfc168c67e0410f9698f8797db223dfc

[7] Dubey JP, Frenkel JK. Cyst-induced toxoplasmosis in cats. The Journal of Protozoology. 1972. URL: https://www.semanticscholar.org/paper/12d02c2160648955e5516f3c6df5f8ca6fc8d0c9

[8] Al-kappany Y, Rajendran C, Ferreira LR, et al. High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation. Journal of Parasitology. 2010. URL: https://www.semanticscholar.org/paper/eb0cb3755cb9a332123f4cff955b60832811f357

[9] Frenkel JK. Toxoplasmosis in cats: diagnosis, treatment and prevention. Comparative Immunology, Microbiology & Infectious Diseases. 1978. URL: https://www.semanticscholar.org/paper/83342586a02084c5abca00f2f74a7c8eaed91493

[10] Dubey JP, Carpenter J. Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association. 1993. URL: https://www.semanticscholar.org/paper/d52209abc2a6337a4c9d08f712a537010200385e

[11] Dubey JP. Toxoplasmosis in cats. 1986. URL: https://www.semanticscholar.org/paper/2d40c71cd859696150a18a7a02da5c18e19cb9f6

[12] Dubey JP, Mattix M, Lipscomb T. Lesions of Neonatally Induced Toxoplasmosis in Cats. Veterinary Pathology-Supplement. 1996. URL: https://www.semanticscholar.org/paper/1254e6ad6e3a8af547409537637842df2c9baaf2

[13] Ahmad N, Ahmed H, Irum S, et al. Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Tropical Biomedicine. 2014. URL: https://www.semanticscholar.org/paper/da6e18e25d3ce94af78a72a188b4814bde5a4bf6

[14] Majid A, Ahmad N, Haleem S, et al. Detection of toxoplasmosis in pets and stray cats through molecular and serological techniques in Khyber Pakhtunkhwa, Pakistan. BMC Veterinary Research. 2021. URL: https://www.semanticscholar.org/paper/8d881c294db66470f8cb1039711b82f9beddee6c

[15] Inpankaew T, Sattasathuchana P, Kengradomkij C, et al. Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand. BMC Veterinary Research. 2021. URL: https://www.semanticscholar.org/paper/9d019b6566281c83eacd73785646da54fbe4f464

[16] Karakavuk M, Can H, Selim N, et al. Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in İzmir, Turkey. Journal of Infection in Developing Countries. 2021. URL: https://www.semanticscholar.org/paper/d4034b4469c570f968226bd0f2428a8841127668

[17] Dubey JP, Hoover E, Walls K. Effect of age and sex on the acquisition of immunity to toxoplasmosis in cats. The Journal of Protozoology. 1977. URL: https://www.semanticscholar.org/paper/23dc34fe496f694a558cf945c5ed25693529c1dd

[18] Germano PM, Melo H, Bianchin I, et al. Toxoplasmosis in cats and dogs. 1980. URL: https://www.semanticscholar.org/paper/28ba5dd1a8560109667f0cde4939e26be92466a8

[19] Cucoș C, Ionașcu I, Mocanu J, et al. Neurological and ocular form of toxoplasmosis in cats. 2015. URL: https://www.semanticscholar.org/paper/aa122640585a7963211031f376cc4dfc5aad4bb2

[20] Bastan I. Clinical and some laboratory findings in cats with Toxoplasmosis. 2018. URL: https://www.semanticscholar.org/paper/22a23aba5dc5ed1ccad8996586a2a1622e64a857

[21] Vainisi SJ, Campbell LH. Ocular toxoplasmosis in cats. 1969. URL: https://www.semanticscholar.org/paper/249b39e2a160380e0392f576ba6c852d4525e72d

[22] Dubey JP, Thulliez P. Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. Journal of the American Veterinary Medical Association. 1989. URL: https://www.semanticscholar.org/paper/ee22536cb0d4e9d5bd35bdcff522943c207f2843

[23] Sabukunze S, Gu H, Zhao L, et al. Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis of Toxoplasma gondii infection in cats. Frontiers in Veterinary Science. 2024. URL: https://www.semantics

[24] Davidson MG, Lappin M, Rottman JR, et al. Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrobial Agents and Chemotherapy. 1996. URL: https://www.semanticscholar.org/paper/3c33146daf33215dac6e658719c1d07bb266fdf7

[25] Shen Y, Zheng B, Sun H, et al. A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infectious Diseases of Poverty. 2023. URL: https://www.semanticscholar.org/paper/2c0eccd9ce92a1acbb4617baa6621f2d56e59c5e

[26] Shahzad A, Khan MS, Ashraf K, et al. Sero-epidemiological and haematological studies on toxoplasmosis in cats, dogs and their owners in Lahore, Pakistan. 2006. URL: https://www.semanticscholar.org/paper/7d0dfdee60bde59fcc72a83a2c3ef69c3c975815

[27] Zafar Z, Ali N, Baleanu D. Dynamics and numerical investigations of a fractional-order model of toxoplasmosis in the population of human and cats. 2021. URL: https://www.semanticscholar.org/paper/db91c7fb65e1a1d56be21460221b7855e2809a5c

[28] Vinogradov LI. Diagnosis of toxoplasmosis in cats. 1980. URL: https://www.semanticscholar.org/paper/547f904162fe1e9133e7b8fbdd7c56c7fd520f18